Insmed (INSM) Goodwill & Intangibles (2010 - 2026)
Insmed (INSM) posted quarterly Goodwill & Intangibles of $231.7 million for Q1 2026, up 70.22% year-over-year from $136.1 million in Q1 2025, and down 0.89% quarter-over-quarter from $233.8 million in Q4 2025.
Insmed (INSM) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Insmed's Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $231.7 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 70.22% year-over-year to $231.7 million; the TTM figure through Mar 2026 stood at $231.7 million (up 70.22% YoY), while the FY2025 annual figure was $233.8 million, up 20.02% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $231.7 million, down from $233.8 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $233.8 million in Q4 2025, with the low at $136.1 million in Q2 2024.
- The 5-year median for Goodwill & Intangibles is $199.8 million (2023), against an average of $187.2 million.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles jumped 343.74% in 2022, then tumbled 34.37% in 2023.
- Insmed's Goodwill & Intangibles stood at $204.9 million in 2022, then declined by 2.47% to $199.8 million in 2023, then slipped by 2.52% to $194.8 million in 2024, then rose by 20.02% to $233.8 million in 2025, then fell by 0.89% to $231.7 million in 2026.
- Business Quant data shows INSM's Goodwill & Intangibles at $231.7 million in Q1 2026, $233.8 million in Q4 2025, and $220.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 229.60 Mn |
| Mar 31, 2026 | 231.67 Mn |
| Dec 31, 2025 | 233.75 Mn |
| Sep 30, 2025 | 220.70 Mn |
| Jun 30, 2025 | 192.24 Mn |
| Mar 31, 2025 | 136.10 Mn |
| Dec 31, 2024 | 194.76 Mn |
| Sep 30, 2024 | 136.10 Mn |
| Jun 30, 2024 | 136.10 Mn |
| Mar 31, 2024 | 198.55 Mn |
| Dec 31, 2023 | 199.80 Mn |
| Sep 30, 2023 | 136.11 Mn |
| Jun 30, 2023 | 136.11 Mn |
| Mar 31, 2023 | 203.60 Mn |
| Dec 31, 2022 | 204.87 Mn |
| Sep 30, 2022 | 206.13 Mn |
| Jun 30, 2022 | 207.38 Mn |
| Mar 31, 2022 | 208.66 Mn |
| Dec 31, 2021 | 209.92 Mn |
| Sep 30, 2021 | 211.18 Mn |